ArticleCurrent issues in molecular biology2022

Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study.

Alberto D'Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.